Jinzi Wu

Jinzi J.
Wu is the founder of Ascletis Biopharmaceutical (Hangzhou) Co. Ltd., founded in 2011, serving as Chairman, President & Chief Executive Officer.
Dr. Wu is the founder of Gannex Pharma Co Ltd., founded in 2019, serving as Chief Executive Officer.
Dr. Wu is the founder of Ascletis Pharma, Inc., founded in 2013, serving as Chairman & Chief Executive Officer.
Current jobs include Chief Executive Officer & Director at Ascletis BioScience Co., Ltd. since 2013; Chief Executive Officer & Director at Ascletis Xinnuo Medicine Co., Ltd since 2018; Director at Ascletis Pharma China Co., Ltd. since 2018; Director at Soundridge Pharmaceuticals (Hong Kong) Co., Ltd. since 2019; Member at The BayHelix Group; and Manager at Gannex LLC since 2020.
Former jobs include Director at Sagimet Biosciences, Inc. from 2019 to 2024; Principal at Immunex Corp.
from 1992 to 2002; Principal at Novartis AG from 1992 to 2002; Vice President at GSK Plc; Principal at Sanofi India Ltd. from 1992 to 2002; Senior Scientist at Novartis Pharmaceuticals Corp.
from 1997 to 2000; Vice President-Preclinical & Basic Research at Ambrilia Biopharma, Inc. from 2004 to 2008; Vice President-Research & Development at PhageTech, Inc. from 2002 to 2004; Vice President at Ascletis Pharmaceuticals Co., Ltd. from 2014 to 2021.
Education includes a doctorate from the University of Arizona conferred in 1996 and undergraduate and graduate degrees from Nanjing University.